Pyruvate kinase deficiency
2,645views
Pyruvate kinase deficiency
hemato
hemato
Sideroblastic anemia
Microcytic anemia: Pathology review
Aplastic anemia
Macrocytic anemia: Pathology review
Anemia: Clinical
Megaloblastic anemia
Extrinsic hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Autoimmune hemolytic anemia
Sickle cell disease (NORD)
Beta-thalassemia
Alpha-thalassemia
Platelet disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Coagulation disorders: Pathology review
Hemophilia
Thrombophlebitis
Disseminated intravascular coagulation
Acute leukemia
Leukemias: Pathology review
Leukemia: Clinical
Chronic leukemia
Post-transplant lymphoproliferative disorders (NORD)
Myelodysplastic syndromes
Langerhans cell histiocytosis
Hemolytic-uremic syndrome
Thrombotic thrombocytopenic purpura
Plasma cell disorders: Pathology review
Plasma cell disorders: Clinical
Waldenstrom macroglobulinemia
Lymphomas: Pathology review
Non-Hodgkin lymphoma
Hodgkin lymphoma
Anti-tumor antibiotics
Blood groups and transfusions
Blood products and transfusion: Clinical
Transplant rejection
Non-corticosteroid immunosuppressants and immunotherapies
Graft-versus-host disease
Ruptured spleen
Hemochromatosis
Iron deficiency anemia
Vitamin B12 deficiency
Folate (Vitamin B9) deficiency
Sickle cell disease: Clinical
Pyruvate kinase deficiency
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Pyruvate dehydrogenase deficiency
Paroxysmal nocturnal hemoglobinuria
Hereditary spherocytosis
Bleeding disorders: Clinical
Vitamin K deficiency
Protein C deficiency
Protein S deficiency
Lymphoma: Clinical
Essential thrombocythemia (NORD)
Myeloproliferative neoplasms: Clinical
Myeloproliferative disorders: Pathology review
Introduction to the immune system
Immune thrombocytopenia
Polycythemia vera (NORD)
Acute intermittent porphyria
Key Takeaways
Pyruvate kinase deficiency is an inherited disorder caused by a mutation in the gene that codes for the enzyme pyruvate kinase. This enzyme is responsible for catalyzing the breakdown of glucose to form pyruvate. Without functional pyruvate kinase, the body is unable to properly convert glucose into energy, which affects the survival of red blood cells and causes them to break down (hemolysis). Symptoms include anemia, fatigue, splenomegaly, and jaundice. Treatment options include blood transfusions, splenectomy for massive splenomegaly, or allogeneic bone marrow transplantation.